Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|31|6|1345-1350

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.31, Iss.6, 2000-06, pp. : 1345-1350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost‐effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantation

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 9, 2015-09 ,pp. : 1055-1065

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation

By  

HEPATOLOGY, Vol. 61, Iss. 5, 2015-05 ,pp. : 1485-1494

John Wiley & Sons Inc

Access to resources Recommend Favorite

Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation

By  

HEPATOLOGY RESEARCH, Vol. 46, Iss. 11, 2016-10 ,pp. : 1118-1128

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sustained virological response to antiviral therapy improves survival rate in patients with recurrent hepatitis C virus infection after liver transplantation

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 11, 2015-11 ,pp. : 1047-1054

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute cellular rejection versus recurrent hepatitis C after liver transplantation: Clinical and pathological features driving a rational diagnostic approach

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 4, 2015-04 ,pp. : 423-431

John Wiley & Sons Inc

Access to resources Recommend Favorite